Ascendis Pharma A (ASND) EBT Margin Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 30,681.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,681.00 |
| Dec 31, 2025 | 87,619.00 |
| Sep 30, 2025 | 107,924.00 |
| Jun 30, 2025 | 129,873.00 |
| Mar 31, 2025 | 174,178.00 |
| Dec 31, 2024 | 11,121.00 |
| Sep 30, 2024 | 704,884.00 |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 830,873.00 |
| Dec 31, 2023 | 17,431.00 |
| Sep 30, 2023 | 408,001.00 |
| Jun 30, 2023 | 636,111.00 |
| Mar 31, 2023 | 252,282.00 |
| Dec 31, 2022 | -68,382.00 |
| Sep 30, 2022 | 1,624.00 |
| Jun 30, 2022 | 51,559.00 |
| Mar 31, 2022 | -84,246.00 |
| Dec 31, 2021 | 890.00 |
| Sep 30, 2021 | -721,843.00 |
| Jun 30, 2021 | 11.39 Mn |